Nick Weber

Company: Vivet Therapeutics

Job title: Principal Scientist - New Programs & Innovation Lead

Seminars:

LNP-Based Therapies for Lasting Relief in Monogenic Liver Disorders 11:30 am

LNP and AAV: comparisons in immunogenicity and toxicity and potential for combinatorial approaches An overview of immunogenicity and toxicity in metabolic liver disease, striving for enhanced targeting and uptake Confronting the challenge of efficiently delivering therapeutic agents to liver cells using LNPsRead more

day: Day One